[go: up one dir, main page]

NO20042185L - Kromatografisk rensing av rekombinant humant erytropoietin - Google Patents

Kromatografisk rensing av rekombinant humant erytropoietin

Info

Publication number
NO20042185L
NO20042185L NO20042185A NO20042185A NO20042185L NO 20042185 L NO20042185 L NO 20042185L NO 20042185 A NO20042185 A NO 20042185A NO 20042185 A NO20042185 A NO 20042185A NO 20042185 L NO20042185 L NO 20042185L
Authority
NO
Norway
Prior art keywords
recombinant human
chromatographic purification
human erythropoietin
erythropoietin
chromatographic
Prior art date
Application number
NO20042185A
Other languages
English (en)
Norwegian (no)
Inventor
Peter Alliger
Norbert Palma
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of NO20042185L publication Critical patent/NO20042185L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/18—Ion-exchange chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/20—Partition-, reverse-phase or hydrophobic interaction chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/505—Erythropoietin [EPO]
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Analytical Chemistry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NO20042185A 2001-11-28 2004-05-26 Kromatografisk rensing av rekombinant humant erytropoietin NO20042185L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US33383901P 2001-11-28 2001-11-28
PCT/EP2002/013299 WO2003045996A1 (fr) 2001-11-28 2002-11-26 Purification chromatographique d'erythropoietine humaine recombinee

Publications (1)

Publication Number Publication Date
NO20042185L true NO20042185L (no) 2004-08-23

Family

ID=23304479

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20042185A NO20042185L (no) 2001-11-28 2004-05-26 Kromatografisk rensing av rekombinant humant erytropoietin

Country Status (20)

Country Link
US (1) US20060099674A1 (fr)
EP (1) EP1453857B1 (fr)
JP (1) JP4293908B2 (fr)
KR (1) KR20040065567A (fr)
CN (1) CN1596268A (fr)
AU (1) AU2002356733A1 (fr)
BR (1) BR0214568A (fr)
CA (1) CA2466627A1 (fr)
ES (1) ES2525945T3 (fr)
HR (1) HRP20040476A2 (fr)
HU (1) HUP0500061A2 (fr)
IL (1) IL161855A0 (fr)
MX (1) MXPA04005189A (fr)
NO (1) NO20042185L (fr)
NZ (1) NZ533083A (fr)
PL (1) PL368755A1 (fr)
RU (1) RU2004119818A (fr)
SI (1) SI1453857T1 (fr)
WO (1) WO2003045996A1 (fr)
ZA (1) ZA200403461B (fr)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003080852A1 (fr) * 2002-03-26 2003-10-02 Lek Pharmaceutical And Chemical Company D.D. Procede de preparation du profil de glyco-isoformesd'erythropoietine recherche
DK1428878T3 (da) * 2002-12-13 2008-12-08 Bioceuticals Arzneimittel Ag Fremgangsmåde til produktion og oprensning af erythropoietin
US7157276B2 (en) 2003-06-20 2007-01-02 Biogen Idec Inc. Use of depth filtration in series with continuous centrifugation to clarify mammalian cell cultures
KR100567448B1 (ko) * 2003-11-05 2006-04-04 주식회사 인투젠 형질전환 동물의 유즙 전처리방법 및 이를 통한 인체단백질의 정제방법
DE102004027816A1 (de) * 2004-06-08 2006-01-05 Bioceuticals Arzneimittel Ag Verfahren zur Reinigung von Erythropoietin
WO2006003926A1 (fr) * 2004-06-30 2006-01-12 Terumo Kabushiki Kaisha Hémoglobine inactivée vis-à-vis des virus et procédé servant à produire celle-ci
US7531632B2 (en) * 2006-02-16 2009-05-12 Gtc Biotherapeutics, Inc. Clarification of transgenic milk using depth filtration
KR100988706B1 (ko) * 2007-03-07 2010-10-18 한미홀딩스 주식회사 재조합 에리트로포이에틴의 신규한 정제방법
KR100900033B1 (ko) * 2007-11-21 2009-06-01 한국생명공학연구원 인간 에리스로포이에틴의 정제방법
DE102008002209A1 (de) 2008-06-04 2009-12-10 Evonik Degussa Gmbh Verfahren zur Aufreinigung von Erythropoietin
EP2307442A4 (fr) 2008-06-24 2012-05-30 Reddys Lab Ltd Dr Purification de cytokines modifiées
EP2337787A1 (fr) * 2008-10-17 2011-06-29 Percivia LLC. Procédé de clarification
DE102008054716A1 (de) * 2008-12-16 2010-06-17 Evonik Degussa Gmbh Inprozesskontrolle in einem Verfahren zur Herstellung von EPO
JP5728016B2 (ja) 2009-09-23 2015-06-03 ラチオファーマ ゲーエムベーハー 組換えヒトエリスロポエチン（ｅｐｏ）を精製するためのプロセス、このようにして精製されたｅｐｏおよびこれを含む医薬組成物
WO2011063195A2 (fr) * 2009-11-20 2011-05-26 Dr. Reddy's Laboratories Ltd. Purification de cytokines modifiées
CN102453087B (zh) * 2010-10-22 2013-12-25 广东赛保尔生物医药技术有限公司 一种单取代peg-epo的纯化及制备方法
WO2012068134A1 (fr) * 2010-11-15 2012-05-24 Biogen Idec Inc. Enrichissement et concentration d'isoformes de produit choisis par liaison surchargée et chromatographie d'élution
WO2012069474A2 (fr) * 2010-11-24 2012-05-31 H. Lundbeck A/S Procédé de réduction de la charge virale potentielle dans un échantillon par un traitement au cyanate
KR101443257B1 (ko) 2011-10-18 2014-09-19 주식회사 종근당 낮은 등전점을 갖는 에리스로포이에틴 유사체의 정제방법
EP2970420A4 (fr) * 2013-03-15 2016-08-17 Apotex Inc Stabilité de la formulation liquide améliorée d'érythropoïétine alpha par l'intermédiaire d'un traitement de purification
JP2016532100A (ja) 2013-07-05 2016-10-13 ラボラトワール・フランセ・デュ・フラクシオンマン・エ・デ・ビョテクノロジーＬａｂｏｒａｔｏｉｒｅ Ｆｒａｎｃａｉｓ Ｄｕ Ｆｒａｃｔｉｏｎｎｅｍｅｎｔ Ｅｔ Ｄｅｓ Ｂｉｏｔｅｃｈｎｏｌｏｇｉｅｓ アフィニティークロマトグラフィーマトリックス
KR101414897B1 (ko) 2013-11-29 2014-07-04 씨제이헬스케어 주식회사 다베포에틴 알파의 정제 방법
WO2015134640A1 (fr) * 2014-03-05 2015-09-11 GlycoScientific LLC Glycanes marqués par des isotopes et leurs procédés de production
EP3233230B1 (fr) 2014-12-15 2024-06-12 Merck Patent GmbH Capture de molécules cibles par des solutions brutes
EP3153522A1 (fr) 2015-10-09 2017-04-12 Hetero Drugs Limited Procédé de purification de l'érythropoïétine et de l'arbépoétine alfa
CN106770597A (zh) * 2017-03-01 2017-05-31 上海博威生物医药有限公司 用于检测组合物中促红细胞生成素电荷异质体的cze检测方法
CN112940101A (zh) * 2019-12-11 2021-06-11 深圳赛保尔生物药业有限公司 重组人促红细胞生成素的纯化方法
CN119198238A (zh) * 2024-09-18 2024-12-27 广东省安家医健健康管理有限公司 一种地中海贫血检测系统及试剂盒

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4677195A (en) * 1985-01-11 1987-06-30 Genetics Institute, Inc. Method for the purification of erythropoietin and erythropoietin compositions
US5856298A (en) * 1989-10-13 1999-01-05 Amgen Inc. Erythropoietin isoforms
ES2131504T3 (es) * 1990-02-20 1999-08-01 Baxter Int Trombina humana purificada viricamente segura.
DE19504211A1 (de) * 1995-02-09 1996-08-14 Behringwerke Ag Entfernen von Viren durch Ultrafiltration aus Proteinlösungen
TW442492B (en) 1995-07-26 2001-06-23 Novartis Ag Process for the enrichment of interferon
ATE241695T1 (de) * 1996-03-13 2003-06-15 Delta Biotechnology Ltd Gärungs-steuerungssysteme
BR9917606A (pt) 1998-11-06 2002-12-31 Bio Sidus S A Procedimento para a purificação de eritropoetina humana recombinante a partir de sobrenadantes de cultivo de células e eritropoetina humana recombinante obtida com tal procedimento

Also Published As

Publication number Publication date
BR0214568A (pt) 2004-11-03
RU2004119818A (ru) 2006-01-10
HUP0500061A2 (hu) 2005-04-28
KR20040065567A (ko) 2004-07-22
JP2005518196A (ja) 2005-06-23
ZA200403461B (en) 2006-05-31
CN1596268A (zh) 2005-03-16
MXPA04005189A (es) 2005-02-17
NZ533083A (en) 2006-09-29
EP1453857B1 (fr) 2014-08-13
CA2466627A1 (fr) 2003-06-05
AU2002356733A1 (en) 2003-06-10
HRP20040476A2 (en) 2005-10-31
IL161855A0 (en) 2005-11-20
ES2525945T3 (es) 2015-01-02
PL368755A1 (en) 2005-04-04
SI1453857T1 (sl) 2015-01-30
JP4293908B2 (ja) 2009-07-08
EP1453857A1 (fr) 2004-09-08
US20060099674A1 (en) 2006-05-11
WO2003045996A1 (fr) 2003-06-05

Similar Documents

Publication Publication Date Title
NO20042185L (no) Kromatografisk rensing av rekombinant humant erytropoietin
DE60211601D1 (de) Bereitstellung von positionsabhängigen Inhalten
ID30262A (id) Ligan reseptor melanokortin
DE50212455D1 (de) Verwendung von Dimerdiolen
DE50209252D1 (de) Distraktionsvorrichtung
FR2830516B1 (fr) Suspension de turboreacteur
DE02784674T1 (de) Quantifizierung von polypeptiden
NO20042433L (no) Syntese og rensing av valasyklovir
NO20044916L (no) Preparater av sulfinylacetamid
DE10295497D2 (de) Vernetzung von Photoinitiator-initialisierten Polyacrylaten
EP1578774A4 (fr) Purification de proteines
ITMI20021038A0 (it) Disposizione di elettrodi
NO20041968L (no) Anvendelse av cystationin
PT1429926E (pt) Circuito de interligacao
NO20031739L (no) Fremgangsmåte for rensing av pravastatin
FI20011414L (fi) Optinen ohjauselementti
IS6884A (is) Aðferðir við að nýta líffræðilegan fjölbreytileika
ATE272388T1 (de) Verwendung von kationischen zubereitungen
DE60131682D1 (de) Biologische bekämpfung von pflanzenkrankheiten
DE50203046D1 (de) Verwendung von Esterquats
ATA2152001A (de) Verwendung von selenhältigen präparaten
DE60225366D1 (de) Expressionskontrollsequenz
ITMI20011820A0 (it) Trattamento di ustioni
HK1071575A (en) Chromatographic purification of recombinant human erythropoietin
EP1551573A4 (fr) Traitement de sous-produits de fusion

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application